Anti-ADAM10 抗体 (ab1997)
Key features and details
- Rabbit polyclonal to ADAM10
- Suitable for: WB, ICC
- Reacts with: Human
- Isotype: IgG
リコンビナント抗体で、ロット間での高い再現性を実現
- 異なるロット間での安定した再現性
- 容易なスケールアップ
- 評価試験による特異性の確認済み
- 倫理基準に準拠 - アニマル・フリーの生産
製品の概要
-
製品名
Anti-ADAM10 antibody
ADAM10 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to ADAM10 -
由来種
Rabbit -
アプリケーション
適用あり: WB, ICCmore details -
種交差性
交差種: Human
交差が予測される動物種: Rat, Cow, Pig
-
免疫原
Synthetic peptide corresponding to Human ADAM10 aa 732-748.
Sequence:PQRQRPRESYQMGHMRR
(Peptide available asab7868) -
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. -
バッファー
pH: 7.2
Preservative: 0.02% Sodium azide
Constituent: PBS -
Concentration information loading... -
精製度
Immunogen affinity purified -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Conjugation kits
-
Immunizing Peptide (Blocking)
-
Isotype control
-
Positive Controls
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab1997の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| WB | (9) |
1/500 - 1/2000. Predicted molecular weight: 84 kDa.Can be blocked with ADAM10 peptide (ab7868).
|
| ICC | (1) |
Use a concentration of 2 µg/ml.
|
| 特記事項 |
|---|
|
WB
1/500 - 1/2000. Predicted molecular weight: 84 kDa.Can be blocked with ADAM10 peptide (ab7868). |
|
ICC
Use a concentration of 2 µg/ml. |
ターゲット情報
-
機能
Cleaves the membrane-bound precursor of TNF-alpha at '76-Ala-
-Val-77' to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Responsible for the proteolytic release of several other cell-surface proteins, including heparin-binding epidermal growth-like factor, ephrin-A2 and for constitutive and regulated alpha-secretase cleavage of amyloid precursor protein (APP). Contributes to the normal cleavage of the cellular prion protein. Involved in the cleavage of the adhesion molecule L1 at the cell surface and in released membrane vesicles, suggesting a vesicle-based protease activity. Controls also the proteolytic processing of Notch and mediates lateral inhibition during neurogenesis. -
組織特異性
Expressed in spleen, lymph node, thymus, peripheral blood leukocyte, bone marrow, cartilage, chondrocytes and fetal liver. -
配列類似性
Contains 1 disintegrin domain.
Contains 1 peptidase M12B domain. -
ドメイン
The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme. -
翻訳後修飾
The precursor is cleaved by a furin endopeptidase. -
細胞内局在
Cell membrane. Endomembrane system. Is localized in the plasma membrane but is predominantly expressed in the Golgi apparatus and in released membrane vesicles derived likely from the Golgi. - Information by UniProt
-
参照データベース
- Entrez Gene: 282132 Cow
- Entrez Gene: 102 Human
- Entrez Gene: 397345 Pig
- Entrez Gene: 29650 Rat
- Omim: 602192 Human
- SwissProt: Q10741 Cow
- SwissProt: O14672 Human
- SwissProt: O77633 Pig
see all -
別名
- A disintegrin and metalloprotease domain 10 antibody
- A disintegrin and metalloproteinase domain 10 antibody
- AD 10 antibody
see all
画像
-
Western blot - Anti-ADAM10 antibody (ab1997)Lane 1 : Anti-ADAM10 antibody (ab1997) at 1 µg/ml
Lane 2 : Anti-ADAM10 antibody (ab1997) at 2 µg/ml
All lanes : Jurkat whole cell lysate
Predicted band size: 84 kDa -
Immunocytochemistry - Anti-ADAM10 antibody (ab1997)ab1997 at 2µg/ml staining K562 cells by ICC/IF. -
Immunocytochemistry - Anti-ADAM10 antibody (ab1997)ICC/IF image of ab1997 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab1997, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. -
Western blot - Anti-ADAM10 antibody (ab1997)This image is courtesy of an anonymous AbreviewAll lanes : Anti-ADAM10 antibody (ab1997) at 1/1666 dilution
Lane 2 : ADAM10 siRNA treated human keratinocyte cells
Lane 3 : Non-treated human keratinocyte cells.
Secondary
All lanes : HRP conjugated Goat anti-rabbit antibody
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 84 kDa
Observed band size: 100,75 kDa why is the actual band size different from the predicted?
Exposure time: 1 minute
-
Immunocytochemistry - Anti-ADAM10 antibody (ab1997)Immunofluorescence of ADAM10 in K562 cells using ab1997 at 10 ug/ml. -
Western blot - Anti-ADAM10 antibody (ab1997)This image is courtesy of an Abreview submitted by Grant CorbettAll lanes : Anti-ADAM10 antibody (ab1997) at 1/1000 dilution
All lanes : Human frontal cortex tissue lysate - whole
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : IRDye® 800CW-conjugated donkey anti-rabbit IgG polyclonal at 1/18000 dilution
Performed under reducing conditions.
Predicted band size: 84 kDa
Observed band size: 65,80 kDa why is the actual band size different from the predicted?
Exposure time: 330 seconds
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (94)
ab1997 は 94 報の論文で使用されています。
- Cheng Y et al. ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc. Cancer Cell Int 21:32 (2021). PubMed: 33413403
- Diaz-Lucena D et al. TREM2 expression in the brain and biological fluids in prion diseases. Acta Neuropathol 141:841-859 (2021). PubMed: 33881612
- Ni XQ et al. Inhibition of Notch1-mediated inflammation by intermedin protects against abdominal aortic aneurysm via PI3K/Akt signaling pathway. Aging (Albany NY) 13:5164-5184 (2021). PubMed: 33535178
- Pichler R et al. Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study. J Clin Med 10:N/A (2021). PubMed: 33672843
- Sánchez-Del-Campo L et al. MITF induces escape from innate immunity in melanoma. J Exp Clin Cancer Res 40:117 (2021). PubMed: 33789714